Multimodal CT Scans for Telling Apart Stroke Look-Alikes
Studies multimodal brain CT scans to identify stroke mimics in adults.
Plain-language title generated from the registry record
Registry title: Multimodal CT Examination in Stroke Mimics Diagnosis
Key facts
- Where
- České Budějovice and Ostrava, CzechiaSee the 3 sites
Where in Czechia
- Hospital České BudějoviceČeské Budějovice, CzechiaTaking people
- University Hospital OstravaOstrava, CzechiaTaking people
- University of OstravaOstrava, CzechiaTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- University Hospital Ostrava
- Trial code
- NCT06045455
- Record updated
- 16 January 2024
- Original description
The proposed project is a multicentre prospective observational clinical research focused on refining multimodal computer tomography (CT) diagnostics in stroke mimics. The main aim is to accurately identify SM in order to minimize the risk of receiving inappropriate treatment and possible development of complications, which can have a negative impact on the patient´s health. The project includes an analysis of pharmacoeconomic parameters. It will examine saved costs in the case of non-administration of unindicated treatment and it will compare the number of adverse events related to the administration of unindicated treatment in patients diagnosed with SM.Read full original descriptionShow less
The Importance of Multimodal CT Examination in Stroke Mimics Diagnosis: a Prospective Observational Multicenter Study
The proposed project is a multicentre prospective observational clinical research focused on refining multimodal computer tomography (CT) diagnostics in stroke mimics. The main aim is to accurately identify SM in order to minimize the risk of receiving inappropriate treatment and possible development of complications, which can have a negative impact on the patient´s health. The project includes an analysis of pharmacoeconomic parameters. It will examine saved costs in the case of non-administration of unindicated treatment and it will compare the number of adverse events related to the administration of unindicated treatment in patients diagnosed with SM.
Inclusion: an acute focal neurological deficit (minimum 1 point on the National Institutes of Health Stroke Scale - NIHSS) within 24 hours from the onset of symptoms.
Exclusion: the last period of normality is unknown prior to multimodal CT examination; the last period of normality is >24 hours prior to multimodal CT examination; the diagnostic evaluation is incomplete; a final neurologic diagnosis cannot be determined.